BreakthroughT1D
Highly Engaged Employees
Non-Profit & Charitable Organizations Ā· New York, United States Ā· 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
200 Vesey St Fl 28, New York City, New Y...Phone Number
(800) 533-2873Website
www.breakthrought1d.orgRevenue
$223.8 MillionIndustry
About BreakthroughT1D
BreakthroughT1D Org Chart
Assistant VP, Donor Engagement
Assistant VP, Content & Storytelling
Assistant VP, Research Partnerships
Assistant VP, Community Engagement
Is BreakthroughT1D your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BreakthroughT1D, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at BreakthroughT1D
Click to see if BreakthroughT1D had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BreakthroughT1D has new funding data
Product Launch: Get notified when BreakthroughT1D launches new products
Check out if BreakthroughT1D is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BreakthroughT1D recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if BreakthroughT1D has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at BreakthroughT1D
Find 2 more new buyers
Company Profile Activity
Activity Insights
BreakthroughT1D is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
BreakthroughT1D is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about BreakthroughT1D.
BreakthroughT1D Tech Stack
A closer look at the technologies used by BreakthroughT1D
Most Recent Scoops
BreakthroughT1D News & Media
Breakthrough T1D Southern Ohio Chapter Hosts 42nd Annual Cincinnatian of the Year Gala, Raising Over $1 Million
NFL Cincinnati Bengals Offensive Tackle Orlando Brown, Jr. Honored as Breakthrough T1D's Cincinnatian of the Year The Super Bowl Champion Donated $100,000 to Breakthrough T1D in Honor of Saturday's Recognition CINCINNATI, May 12, 2026 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the...Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
NEW YORK, April 22, 2026 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision by the U.S. Food and Drug Administration (FDA) to approve Sanofi's Tzield (teplizumab-mzwv) for use in children...Breakthrough T1D Announces New International Board of Directors Leadership
Karen Shishino Jordan Named Chair and Carlton McMillan Named Vice Chair During a Period of Historic Type 1 Diabetes Scientific Progress NEW YORK, April 15, 2026 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization,...Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHEĀ® Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes CARY, N.C. and NEW YORK, March 24, 2026 /PRNewswire/ -- Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to advance Continuity's NICHEĀ® cell-therapy platform toward a planned first-in-human clinical study for people living with T1D. The effort is supported through Breakthroug
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BreakthroughT1D
As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate an... Read More